IBDEI0IV ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8771,1,4,0)
 ;;=4^H57.00
 ;;^UTILITY(U,$J,358.3,8771,2)
 ;;=^5006375
 ;;^UTILITY(U,$J,358.3,8772,0)
 ;;=H57.9^^41^468^68
 ;;^UTILITY(U,$J,358.3,8772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8772,1,3,0)
 ;;=3^Eye and Adnexa Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,8772,1,4,0)
 ;;=4^H57.9
 ;;^UTILITY(U,$J,358.3,8772,2)
 ;;=^269333
 ;;^UTILITY(U,$J,358.3,8773,0)
 ;;=L10.9^^41^468^126
 ;;^UTILITY(U,$J,358.3,8773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8773,1,3,0)
 ;;=3^Pemphigus,Unspec
 ;;^UTILITY(U,$J,358.3,8773,1,4,0)
 ;;=4^L10.9
 ;;^UTILITY(U,$J,358.3,8773,2)
 ;;=^5009090
 ;;^UTILITY(U,$J,358.3,8774,0)
 ;;=L10.81^^41^468^124
 ;;^UTILITY(U,$J,358.3,8774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8774,1,3,0)
 ;;=3^Paraneoplastic Pemphigus
 ;;^UTILITY(U,$J,358.3,8774,1,4,0)
 ;;=4^L10.81
 ;;^UTILITY(U,$J,358.3,8774,2)
 ;;=^5009088
 ;;^UTILITY(U,$J,358.3,8775,0)
 ;;=L10.5^^41^468^60
 ;;^UTILITY(U,$J,358.3,8775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8775,1,3,0)
 ;;=3^Drug-Induced Pemphigus
 ;;^UTILITY(U,$J,358.3,8775,1,4,0)
 ;;=4^L10.5
 ;;^UTILITY(U,$J,358.3,8775,2)
 ;;=^5009087
 ;;^UTILITY(U,$J,358.3,8776,0)
 ;;=L12.9^^41^468^125
 ;;^UTILITY(U,$J,358.3,8776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8776,1,3,0)
 ;;=3^Pemphigoid,Unspec
 ;;^UTILITY(U,$J,358.3,8776,1,4,0)
 ;;=4^L12.9
 ;;^UTILITY(U,$J,358.3,8776,2)
 ;;=^5009102
 ;;^UTILITY(U,$J,358.3,8777,0)
 ;;=M35.01^^41^468^153
 ;;^UTILITY(U,$J,358.3,8777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8777,1,3,0)
 ;;=3^Sicca Syndrome w/ Keratoconjunctivitis
 ;;^UTILITY(U,$J,358.3,8777,1,4,0)
 ;;=4^M35.01
 ;;^UTILITY(U,$J,358.3,8777,2)
 ;;=^5011787
 ;;^UTILITY(U,$J,358.3,8778,0)
 ;;=S05.01XA^^41^468^89
 ;;^UTILITY(U,$J,358.3,8778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8778,1,3,0)
 ;;=3^Injury of Conjunctiva/Corneal Abrasion w/o FB,Right Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,8778,1,4,0)
 ;;=4^S05.01XA
 ;;^UTILITY(U,$J,358.3,8778,2)
 ;;=^5020579
 ;;^UTILITY(U,$J,358.3,8779,0)
 ;;=S05.02XA^^41^468^90
 ;;^UTILITY(U,$J,358.3,8779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8779,1,3,0)
 ;;=3^Injury of Conjunctiva/Corneal Abrasion w/o FB,Left Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,8779,1,4,0)
 ;;=4^S05.02XA
 ;;^UTILITY(U,$J,358.3,8779,2)
 ;;=^5020582
 ;;^UTILITY(U,$J,358.3,8780,0)
 ;;=T15.02XA^^41^468^69
 ;;^UTILITY(U,$J,358.3,8780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8780,1,3,0)
 ;;=3^FB in Cornea,Left Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,8780,1,4,0)
 ;;=4^T15.02XA
 ;;^UTILITY(U,$J,358.3,8780,2)
 ;;=^5046387
 ;;^UTILITY(U,$J,358.3,8781,0)
 ;;=T15.01XA^^41^468^70
 ;;^UTILITY(U,$J,358.3,8781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8781,1,3,0)
 ;;=3^FB in Cornea,Right Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,8781,1,4,0)
 ;;=4^T15.01XA
 ;;^UTILITY(U,$J,358.3,8781,2)
 ;;=^5046384
 ;;^UTILITY(U,$J,358.3,8782,0)
 ;;=T15.91XA^^41^468^72
 ;;^UTILITY(U,$J,358.3,8782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8782,1,3,0)
 ;;=3^FB on External Eye,Right Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,8782,1,4,0)
 ;;=4^T15.91XA
 ;;^UTILITY(U,$J,358.3,8782,2)
 ;;=^5046411
 ;;^UTILITY(U,$J,358.3,8783,0)
 ;;=T15.92XA^^41^468^71
 ;;^UTILITY(U,$J,358.3,8783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8783,1,3,0)
 ;;=3^FB on External Eye,Left Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,8783,1,4,0)
 ;;=4^T15.92XA
 ;;^UTILITY(U,$J,358.3,8783,2)
 ;;=^5046414
 ;;^UTILITY(U,$J,358.3,8784,0)
 ;;=T85.398A^^41^468^118
 ;;^UTILITY(U,$J,358.3,8784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8784,1,3,0)
 ;;=3^Mech Compl of Ocular Prosthetic Device/Implant/Graft,Init Encntr
